CLOPIDOGREL


Synonyms	Clopidogrel Clopidogrel 1a-pharma Clopidogrel acino Clopidogrel apotex Clopidogrel benzenesulfonate Clopidogrel besilate Clopidogrel besylate Clopidogrel hexal Clopidogrel sandoz Clopidogrel-ratiopharm Grepid Iscover NSC-758613 Plavix R 130964 R-130964 SR 25990 SR-25990 Zyllt
Status
Molecule Category	Free-form
ATC	B01AC04
UNII	A74586SNO7
EPA CompTox	DTXSID6022848


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	GKTWGGQPFAXNFI-HNNXBMFYSA-N
Smiles	COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1
InChI	InChI=1S/C16H16ClNO2S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14/h2-5,7,9,15H,6,8,10H2,1H3/t15-/m0/s1

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C16H16ClNO2S
Molecular Weight	321.83
AlogP	3.67
Hydrogen Bond Acceptor	4.0
Hydrogen Bond Donor	0.0
Number of Rotational Bond	3.0
Polar Surface Area	29.54
Molecular species	NEUTRAL
Aromatic Rings	2.0
Heavy Atoms	21.0

Related Entries

Environmental Exposure

Environmental Exposure Map

Countries
Croatia
Czech Republic
Germany
Hungary
Romania
Serbia
Slovenia

Cross References

Resources	Reference
ChEBI	37941
ChEMBL	CHEMBL1771
DrugBank	DB00758
DrugCentral	708
FDA SRS	A74586SNO7
Human Metabolome Database	HMDB0005011
Guide to Pharmacology	7150
KEGG	D07729
PDB	CGE
PharmGKB	PA449053
PubChem	60606
SureChEMBL	SCHEMBL4769
ZINC	ZINC000034781704

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).